RNA Insights

Dive into our team's latest insights about life sciences deal making, transaction support and value creation.

The Autoimmune Organization: How Toxic Team Members Destroy Value in Small Firms

The Autoimmune Organization: How Toxic Team Members Destroy Value in Small Firms

Most founders and CEOs understand bad clients. A... [read more]

Human Capital - Your Org Chart's Link to Value

Human Capital: Your Org Chart’s Link to Value

It’s Not Always Positive Ask a biotech CEO... [read more]

The Story Everyone Believed

The Story Everyone Believed

Unfortunately, this actually happened. I. The Worldview Before... [read more]

The Valuation Trap: When Accounting Standards Freeze What Should Be Fluid

The Valuation Trap: When Accounting Standards Freeze What Should Be Fluid

Why Biotech Executives and Investors Should Understand the... [read more]

What's Your Corporate RNA?

What’s Your Corporate RNA?

Data-Driven Narrative for Capital Formation in Life Sciences... [read more]

Fairness Opinions: Why Expertise Matters Now More Than Ever in Life Sciences and Healthcare

Since 2015, RNA Advisors has provided valuation, transactional... [read more]

Scott Winder joins RNA to expand its Life Science Tax and Financial Reporting Valuation Group

RNA Advisors, LLC, a leading valuation and strategic... [read more]

Client Success: Healthcare Transaction Support to Assess Value from Different Perspectives

THE SITUATION: A healthcare company with a portfolio... [read more]

Client Success: Mandatory Adoption of ASC 842 – Incremental Borrowing Rate Analysis for Private Biotech

The Situation: Adoption of ASC 842 – Lease... [read more]

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.